RadVault

Associated Features

5 min read

Associated Features

Associated features are findings usually seen with other significant primary findings (Masses, Non-Mass Enhancement) but may occasionally be stand-alone entities. They are often associated with or suspicious for breast cancer and are particularly important when they influence surgical management and/or breast cancer staging. Unlike primary findings, associated features are not independently assigned a BI-RADS category but modify the overall clinical picture and may upstage disease.

Eight Associated Features

FeatureKey PointsStaging Impact
Associated Feature — Nipple RetractionNipple pulled inward; distinguish from congenital nipple inversionMay indicate central tumor involvement
Associated Feature — Nipple InvolvementMalignant enhancement contiguous with or extending into the nippleAffects surgical planning (nipple-sparing vs. simple mastectomy)
Associated Feature — Skin RetractionSkin pulled inward; benign if post-surgical and stableMay indicate superficial tumor tethering
Associated Feature — Skin ThickeningDiffuse or focal; threshold > 2 mmDiffuse thickening raises concern for inflammatory breast cancer (T4d)
Associated Feature — Skin InvolvementDefinitive abnormal enhancing skin, not just thickeningT4b if direct tumor invasion of skin
Associated Feature — Pectoralis Muscle InvolvementEnhancement extends into pectoralis major and/or minorDoes NOT constitute chest wall invasion; does NOT upstage to T4a
Associated Feature — Chest Wall InvolvementEnhancement into intercostal muscles, serratus anterior, or ribsUpstages to T4a; may preclude surgery
Associated Feature — Peritumoral EdemaT2 hyperintense signal surrounding tumorNew in v2025; associated with higher nodal metastasis risk

Imaging Appearance

How to Evaluate Associated Features

Associated features are assessed on multiple MRI sequences:

SequenceWhat to Look For
T1W pre-contrastSkin thickening, architectural distortion, nipple retraction
T2W / STIRPeritumoral edema (high signal surrounding mass), skin thickening, chest wall edema
T1W post-contrast (subtraction)Abnormal enhancement of skin, nipple, pectoralis, chest wall; contiguous enhancement from primary tumor
DWIRestricted diffusion in chest wall or skin may confirm tumor involvement

Distinguishing True Involvement from Abutment

A lesion that abuts the pectoralis muscle or skin is not the same as involvement. True involvement requires one or more of:

  • Abnormal enhancement within the structure
  • Loss of the normal fat plane between tumor and muscle/skin
  • Morphologic distortion of the involved structure

Board Pearl

Abutment ≠ involvement. A mass touching the pectoralis fascia without enhancement within the muscle is NOT pectoralis involvement. Look for abnormal enhancement extending INTO the muscle fibers or loss of the intervening fat plane.

Staging Implications

Associated features directly affect AJCC TNM staging and surgical decision-making:

FeatureTNM ImpactManagement Change
Skin involvement (direct invasion)T4bMay require mastectomy; neoadjuvant chemotherapy considered
Chest wall involvementT4aOften inoperable without neoadjuvant therapy
Skin thickening + skin involvement + inflammatory signsT4d (inflammatory)Neoadjuvant chemotherapy mandatory; surgery delayed
Pectoralis involvement onlyNOT T4aResectable with en bloc pectoralis excision
Nipple involvementDoes not change T stagePrecludes nipple-sparing mastectomy

Board Pearl

Pectoralis muscle involvement is NOT chest wall involvement in breast cancer staging. The chest wall = intercostal muscles + serratus anterior + osseous structures (ribs, sternum). The pectoralis major and minor sit anterior to the chest wall. This distinction has critical implications: pectoralis involvement does NOT upstage to T4a and remains surgically resectable.

Board Pearl

Diffuse skin thickening + trabecular thickening + diffuse breast edema on MRI should raise concern for inflammatory breast cancer (T4d), even if no discrete mass is identified. Clinical correlation (peau d’orange, erythema involving ≥1/3 of the breast) is required for the diagnosis.

v2025 Changes

Peritumoral Edema — New Associated Feature

Peritumoral edema was added as a new (eighth) associated feature in BI-RADS v2025. It was not included in the 5th edition lexicon.

  • Defined as T2 hyperintense signal surrounding a malignant or suspicious finding
  • Best seen on T2W or STIR sequences
  • Associated with larger tumor size, higher tumor grade, and increased risk of axillary lymph node metastases
  • Extensive peritumoral edema may predict lymphovascular invasion (LVI)
  • Should be specifically reported when present, as it may influence decisions regarding axillary staging (sentinel node biopsy vs. axillary dissection)

Edition Conflict

The 5th edition of BI-RADS MRI did not list peritumoral edema as an associated feature. v2025 now formally includes it. Any reference to “seven associated features” reflects the prior edition; the current count is eight.

Pitfalls and Common Mistakes

  1. Confusing nipple retraction with nipple inversion — Congenital nipple inversion is bilateral, stable, and present since puberty. Acquired nipple retraction is unilateral, new, and associated with underlying malignancy. Always compare with prior imaging and the contralateral side.

  2. Overcalling pectoralis involvement — Post-contrast enhancement in the pectoralis can be physiologic (e.g., after exercise or biopsy). Confirm with subtraction images and correlation with mass location.

  3. Misinterpreting reactive skin thickening — Post-biopsy, post-radiation, and dependent (inferior breast) skin thickening are common benign causes. Clinical history and comparison with priors are essential.

  4. Ignoring peritumoral edema — Because it is new to the lexicon, radiologists accustomed to the 5th edition may not report it. Actively evaluate T2W sequences around every suspicious mass.

  5. Confusing chest wall with pectoralis — This error directly impacts staging. The pectoralis muscles are NOT part of the chest wall. Only intercostal muscles, serratus anterior, and ribs constitute the chest wall.

Clinical Significance

  • Associated features should be systematically reported in every breast MRI, even when the primary finding is the focus
  • Multiple associated features occurring together increase the pre-test probability of malignancy and may warrant more aggressive management
  • In the setting of neoadjuvant chemotherapy, associated features should be re-evaluated on follow-up MRI to assess treatment response (e.g., resolution of skin thickening, decreased peritumoral edema)
  • Bilateral skin thickening suggests systemic causes (heart failure, renal failure, anasarca) rather than malignancy

Board Pearl

When reporting breast MRI, systematically evaluate all eight associated features — even when absent. Documenting their absence is as important as documenting their presence, particularly for surgical planning and staging.

Graph View

Backlinks